Analystreport

Adamis Pharmaceuticals Corp (NASDAQ: ADMP) was upgraded by analysts at Dawson James to a "buy" rating. They now have a $1.00 price target on the stock.

Adamis Pharmaceuticals Corporation  (ADMP) 
Last adamis pharmaceuticals corporation earnings: 11/12 04:16 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.adamispharmaceuticals.com/investor-overview